Guardion Health Sciences, Inc.
GHSIOTCHealthcare
$3.25
+$0.03(+0.93%)
Market Cap$4173452
P/E Ratio—
52W High$18
52W Low$3.04
Guardion Health Sciences, Inc. (GHSI) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GHSI · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $12.25M | $11.05M | $7.23M | $1.89M | $0.90M |
| Cost of Revenue | $6.85M | $6.53M | $4.12M | $1.95M | $0.34M |
| Gross Profit | $5.39M | $4.52M | $3.11M | ($0.06M) | $0.56M |
| Gross Margin %(computed) | 44.04% | 40.91% | 43.00% | -3.01% | 62.20% |
| Operating Expenses | |||||
| R&D Expenses | $0.15M | $0.19M | $0.06M | $0.16M | $0.19M |
| G&A Expenses | $7.48M | $9.58M | $11.20M | $6.83M | $7.43M |
| Total Operating Expenses | $9.73M | $11.84M | $13.59M | $8.45M | $9.50M |
| Operating Income | ($4.34M) | $0.43M | ($10.48M) | ($8.55M) | ($8.93M) |
| Operating Margin %(computed) | -35.40% | 3.92% | -144.94% | -452.51% | -989.37% |
| Interest Income | $0.38M | $0.15M | $0.00M | $0.00M | $0.26M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.01M | $0.26M |
| Income Before Tax | $0.16M | ($14.92M) | ($24.75M) | ($8.57M) | ($10.88M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | $0.16M | ($30.28M) | ($24.75M) | ($8.58M) | ($11.14M) |
| Net Margin %(computed) | 1.29% | -274.01% | -342.11% | -453.95% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.12 | $-27.01 | $-52.23 | $-180.53 | $-91.61 |
| Wtd Avg Shares | 1.27M | 1.12M | 0.47M | 0.05M | 0.12M |
| EBITDA | ($3.92M) | ($6.07M) | ($9.70M) | ($8.34M) | ($9.99M) |
| EBITDA Margin %(computed) | -32.02% | -54.95% | -134.11% | -441.56% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Guardion Health Sciences, Inc. data
About Guardion Health Sciences, Inc. (GHSI) Income Statement
Guardion Health Sciences, Inc. (GHSI) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, GHSI reported revenue of $0.01B, gross profit of $0.01B (gross margin 44.04%), and net income of $0.00B — a net profit margin of 1.29%.
Frequently asked questions
GHSI · 4 questionsGuardion Health Sciences, Inc. (GHSI) reported revenue of $0.01B for 2023, up 10.8% year-over-year.
GHSI revenueGHSI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09